In this study we implemented an axillary SLN invasion model to develop highly sensitive imaging strategies enabling detection of a very small amount of tumor cells. A highly diffusible molecular probe targeting αvβ3 and αvβ5 integrins was investigated either via IV or locoregional injections. We additionally documented the potential interferences of this Near Infrared Fluorescence Probe with Blue Patente V and ICG dyes routinely used to facilitate lymph node detection during surgery. The human mammary adenocarcinoma MDA-MB-231-luc model was injected into the forepaw of nude female rats to obtain a controlled invasion of the axillary LN. Thanks to its high sensitivity, BLI was selected to achieve in vivo quantitation of tumor cells in SLNs and determine eligible animals for the study. NIRF of integrins was performed at 680 nm both in vivo and ex vivo using spectral unmixing to suppress auto-fluorescence signal and preserve sensitivity. In vivo BLI was quite reliable in estimating discrete invasion by cancer cells in the LN with thresholds of detection and quantitation of about 500 and 1500 cells respectively. For fluorescence at 680 nm, in vivo imaging is not suitable to detect micro-invasion, but ex vivo fluorescence with spectral unmixing of SLNs confirmed the presence of a tumor burden as low as 1500 cells expressing αvβ3/αvβ5 integrins. Targeting few tumor cells inside a micro-invaded sentinel lymph node by molecular probes is not sensitive enough to provide direct in vivo or peroperative imaging. At the time NIRF is performed on the excised specimen, high sensitivity imaging associated with spectral unmixing allowed such detection within less than 1 minute of examination.
References
[1]
Suman, B.M., Gao, S., Zhu, N., Liang, R., Gruev, V. and Achilefu, S. (2014) Real-Time Fluorescence Image-Guided Oncologic Surgery. Advances in Cancer Research, 124, 171-211. https://doi.org/10.1016/B978-0-12-411638-2.00005-7
[2]
David, S. (2003) Nathanson. Insights into the Mechanisms of Lymph Node Metastasis. Cancer, 98, 413-423. https://doi.org/10.1002/cncr.11464
[3]
Ohi, Y., Umekita, Y., Sagara, Y., Rai, Y., Yotsumoto, D., Matsukata, A., et al. (2012) Whole Sentinel Lymph Node Analysis by a Molecular Assay Predicts Axillary Node Status in Breast Cancer. British Journal of Cancer, 107, 1239-1243. https://doi.org/10.1038/bjc.2012.387
[4]
Brambilla, T., Fiamengo, B., Tinterri, C., Testori, A., Grassi, M.M., Sciarra, A., et al. (2015) One-Step Nucleic Acid Amplification in Breast Cancer Sentinel Lymph Node: A Single Institutional Experience and a Short Review. Frontiers in Medicine (Lausanne), 2, 37. https://doi.org/10.3389/fmed.2015.00037
[5]
Themelis, G., Harlaar, N.J., Kelder, W., Bart, J., Sarantopoulos, A., Van Dam, G., et al. (2011) Enhancing Surgical Vision by Using Real-Time Imaging of αvβ3-Integrin Targeted Near-Infrared Fluorescent Agent. Translational Research. Annals of Surgical Oncology, 18, 3506-3513. https://doi.org/10.1245/s10434-011-1664-9
[6]
Lyman, G.H., Temin, S., Edge, S.N., Newman, L.A., Turner, R.R., Weaver, D.L., et al. (2014) Sentinel Lymph Node Biopsy for Patients with Early-Stage Breast Cancer. Journal of Clinical Oncology, 32, 1365-1383. https://doi.org/10.1200/JCO.2013.54.1177
[7]
Gojon, H., Fawunmi, D. and Valachis, A. (2014) Sentinel Lymph Node Biopsy in Patients with Microinvasive Breast Cancer: A Systematic Review and Meta-Analysis. European Journal of Surgical Oncology, 40, 5-11. https://doi.org/10.1016/j.ejso.2013.10.020
[8]
Takeuchi, H. and Yuko, K. (2015) Sentinel Lymph Node Biopsy in Gastric Cancer. Cancer Journal, 21, 21-24.
[9]
Fujimura, T., Fushida, S., Tsukada, T., Kinoshita, J., Oyama, K., Miyashita, T., et al. (2015) A New Stage of Sentinel Node Navigation Surgery in Early Gastric Cancer. Gastric Cancer, 18, 210-217. https://doi.org/10.1007/s10120-014-0446-z
[10]
Handgraaf, H.J., Boogerd, L.S., Verbeek, F.P., Tummers, Q.R., Hardwick, J.C., Baeten, C.I., et al. (2016) Intraoperative Fluorescence Imaging to Localize Tumors and Sentinel Lymph Nodes in Rectal Cancer. Minimally Invasive Therapy & Allied Technologies, 25, 48-53. https://doi.org/10.3109/13645706.2015.1042389
[11]
Niu, G. and Chen, X. (2015) Lymphatic Imaging: Focus on Imaging Probes. Theranostics, 5, 686-697. https://doi.org/10.7150/thno.11862
[12]
Li, L., Shiro Mori, S., Sakamoto, M., Takahashi, S. and Kodama, T. (2013) Mouse Model of Lymph Node Metastasis via Afferent Lymphatic Vessels for Development of Imaging Modalities. PLoS ONE, 8, e55797. https://doi.org/10.1371/journal.pone.0055797
[13]
Bach-Gansmo, T., Danielsson, R., Saracco, A., Wilsczek, B., Bogsrud, T., Fangberget, A., et al. (2007) Integrin Receptor Imaging of Breast Cancer: A Proof-of-Concept Study to Evaluate 99mTc-NC100692. Journal of Nuclear Medicine, 47, 1434-1439.
[14]
Atallah, I., Milet, C., Quatre, R., Henty, M., Reyt, E., Coll, J.L., et al. (2015) Role of Near-Infrared Fluorescence Imaging in the Resection of Metastatic Lymph Nodes in an Optimized Orthotopic Animal Model of HNSCC. European Annals of Otorhinolaryngology, Head and Neck Diseases, 132, 337-342. https://doi.org/10.1016/j.anorl.2015.08.022
[15]
Adams, K.E., Ke, S., Kwon, S., Liang, F., Lu, Y., Hirschi, K., et al. (2007) Comparison of Visible and Near-Infrared Wavelength-Excitable Fluorescent Dyes for Molecular Imaging of Cancer. Journal of Biomedical Optics, 12, Article ID: 024017. https://doi.org/10.1117/1.2717137
[16]
Desgrosellier, J.S. and Cheresh, D.A. (2010) Integrins in Cancer: Biological Implications and Therapeutic Opportunities. Nature Reviews Cancer, 10, 9-22. https://doi.org/10.1038/nrc2748